Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

[edit this page]

MeSH Review:

Hemorrhagic Fevers, Viral

Lloyd, E.S. et al., Halstead, S.B., Ruf, W., Uckun, F.M. et al., Watts, D.M. et al.

Ruf, Uckun, Petkevich, Vassilev, Tibbles, Titov,

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Hemorrhagic Fevers, Viral

Stampidine prevents mortality in an experimental mouse model of viral hemorrhagic fever caused by lassa virus [1].
Activation of coagulation by tissue factor (TF) is frequently observed in sepsis syndrome and is documented in certain viral hemorrhagic fevers [2].

High impact information on Hemorrhagic Fevers, Viral

The use of a formalin-fixed skin specimen for laboratory confirmation of EHF can provide an appropriate method for EHF surveillance when linked with physician training, use of viral hemorrhagic fever isolation precautions, and follow-up investigation [3].
Inhibition of Crimean-Congo hemorrhagic fever viral infectivity yields in vitro by ribavirin [4].
It will be of interest to establish whether other viral hemorrhagic fevers involve the same target cells as in DHF/DSS and are mediated by similar effector mechanisms [5].

References

Stampidine prevents mortality in an experimental mouse model of viral hemorrhagic fever caused by lassa virus. Uckun, F.M., Petkevich, A.S., Vassilev, A.O., Tibbles, H.E., Titov, L. BMC Infect. Dis. (2004) [Pubmed]
Emerging roles of tissue factor in viral hemorrhagic fever. Ruf, W. Trends Immunol. (2004) [Pubmed]
Long-term disease surveillance in Bandundu region, Democratic Republic of the Congo: a model for early detection and prevention of Ebola hemorrhagic fever. Lloyd, E.S., Zaki, S.R., Rollin, P.E., Tshioko, K., Bwaka, M.A., Ksiazek, T.G., Calain, P., Shieh, W.J., Kondé, M.K., Verchueren, E., Perry, H.N., Manguindula, L., Kabwau, J., Ndambi, R., Peters, C.J. J. Infect. Dis. (1999) [Pubmed]
Inhibition of Crimean-Congo hemorrhagic fever viral infectivity yields in vitro by ribavirin. Watts, D.M., Ussery, M.A., Nash, D., Peters, C.J. Am. J. Trop. Med. Hyg. (1989) [Pubmed]
Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade. Halstead, S.B. Rev. Infect. Dis. (1989) [Pubmed]

Contributions to this collaborative article are from individual authors of WikiGenes or mined by the WikiGenes Data Mining Engine from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.About WikiGenes Open Access Licence Privacy Policy Terms of Use apsburg

The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

Editor

Share